<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kitahara</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Maruyama</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Maeshima</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Makita</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Miyamoto</surname>
    <given-names>KI</given-names>
   </name>
   <name>
    <surname>Fukuhara</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Munakata</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Kobayashi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Tajima</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Terauchi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Kurihara</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Taiguchi</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Komatsu</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Tobinai</surname>
    <given-names>K</given-names>
   </name>
  </person-group>
  <article-title>Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment</article-title>
  <source>Ann Hematol</source>
  <year>2017</year>
  <volume>96</volume>
  <fpage>411</fpage>
  <lpage>420</lpage>
  <pub-id pub-id-type="doi">10.1007/s00277-016-2891-8</pub-id>
  <pub-id pub-id-type="pmid">27928587</pub-id>
 </element-citation>
</ref>
